AptarGroup, Inc. (ATR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
AptarGroup, Inc. (ATR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
AptarGroup Q2 Earnings Beat Estimates on Pharma & Beverage Growth
ATR tops Q2 earnings and revenue estimates as pharma and beverage growth lift quarterly revenues above $1B for the first time despite margin pressure.
Why AptarGroup (ATR) International Revenue Trends Deserve Your Attention
Review AptarGroup's (ATR) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
AptarGroup, Inc. (ATR) Q2 2026 Earnings Call Transcript
AptarGroup, Inc. (ATR) Q2 2026 Earnings Call Transcript
AptarGroup Q2 Earnings Call Highlights
AptarGroup NYSE: ATR reported second-quarter sales growth across each of its three segments and adjusted earnings per share above its guidance range, supported by stronger-than-expected performance in its Pharma business. The company also said President and CEO Stephan Tanda will retire later this year, with President and CEO Designate Gael Touya set to assume the CEO role on Sept.
AptarGroup (ATR) Tops Q2 Earnings and Revenue Estimates
AptarGroup (ATR) came out with quarterly earnings of $1.42 per share, beating the Zacks Consensus Estimate of $1.34 per share. This compares to earnings of $1.66 per share a year ago.
AptarGroup (ATR) Expected to Beat Earnings Estimates: Should You Buy?
AptarGroup (ATR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will AptarGroup (ATR) Beat Estimates Again in Its Next Earnings Report?
AptarGroup (ATR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
AptarGroup, Inc. (ATR) Presents at 16th Annual Wells Fargo Industrials & Materials Conference Transcript
AptarGroup, Inc. (ATR) Presents at 16th Annual Wells Fargo Industrials & Materials Conference Transcript
AptarGroup Sets CEO Succession as 2025 Sales Rise and Shareholders Back Ballot
AptarGroup NYSE: ATR used its annual meeting to announce a planned chief executive transition, report that shareholders approved all items on the ballot and provide an update on 2025 performance and early 2026 results.
AptarGroup Q1 Earnings Beat Estimates but Decline Y/Y, Shares Dip 1%
ATR tops Q1 earnings estimates on strong sales growth, but profit declines, pharma headwinds and margin pressure send shares down despite an upbeat Q2 outlook.
AptarGroup, Inc. (ATR) Q1 2026 Earnings Call Transcript
AptarGroup, Inc. (ATR) Q1 2026 Earnings Call Transcript
